Navigation Links
Gentag, Inc. and MacroArray Technologies Join Forces
Date:6/9/2008

WASHINGTON, June 9 /PRNewswire/ -- Gentag, Inc. and MacroArray Technologies, LLC have entered into a development program to design a wireless immunoassay incorporating Gentag's cell phone communication technology and MacroArray's urine diagnostic test for prostate cancer.

One in six males are at risk of developing prostate cancer, but unfortunately not all men are being tested. In order to simplify and expand the use of low cost wireless diagnostic assays for early cancer detection, Gentag, Inc. and MacroArray Technologies have teamed to develop a new wireless test platform that will incorporate Gentag's cell phone-sensor technology with MacroArray's proteomics discovery technology to create a series of new, patient friendly, disposable, wireless diagnostic tests. The first of these will be a test for prostate cancer based on MacroArray's proprietary reagents.

Similar to the currently available pregnancy strip test, men will place a urine sample on the test strip that incorporates an imbedded wireless sensor tag. The antibodies in the strip test will react with the antigens in the urine, the resulting data will be sensed by the imbedded electronic tag and communicated to a cell phone or PDA that will process the data and transmit the results to the attending physician.

During the past year, approximately 60 million PSA tests were performed worldwide and over 200,000 men were diagnosed with prostate cancer. Nearly 35,000 will die each year from the disease. It is hoped that the availability of a simple low cost urine-based test will increase the number of men who evaluate their prostate health on a regular basis.

"The proprietary technology from Gentag combined with MacroArray's biomarkers will provide a significant level of exclusivity in this market," commented Dr. John Peeters, CEO of Gentag. "The combination of our two companies will dramatically expand the utility of our diagnostic tests," commented Mr. Mike Wassil, CEO of MacroArray.

About MacroArray Technologies

MacroArray Technologies is a theranostics company with a proprietary proteomics discovery platform that provides the rapid ability to identify novel biomarkers for diseases such as cancer. Their goal is to provide products for early detection leading to better medical and economic outcomes. The company has a number of tests in development including the Pre-Malignant Prostate cancer and an early stage biomarker for colon cancer.

About Gentag, Inc.

Gentag, Inc. is a technology development company focusing on innovative, low-cost, wireless sensor network technologies based on cell phones. The company owns unique intellectual property relating to cell phone-sensor combinations and wireless sensor networks, including patents 7,109,859 and 7,148,803. The effective combination of cell phone reader technology with a disposable sensor platform has led to a variety of medical diagnostic applications providing consumers, physicians, and various industries with instant access to vital information over established wireless networks, the Internet, and client-specific databases. The company is the recipient of the 2008 North American Technology Innovation Award from Frost & Sullivan.

For inquiries, please contact Marc Onigman at (617)-413-2830. For licensing or investment opportunities please contact Mr. Tom Stagnaro at tom.stagnaro@gentag.com.

For more information, visit:

http://www.gentag.com/

http://www.macroarraytechnologies.com/


'/>"/>
SOURCE Gentag, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
4. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. Advanced technologies aim to transform the coaching of top athletes
7. Global Med Technologies(R) Extends Its Worldwide Outreach
8. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Neurobiological Technologies Reports Going Concern Qualification
11. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... Viejo, California (PRWEB) , ... June 26, 2016 , ... ... Final Cut Pro X. , "Film editors can give their videos a whole new ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology: